3Indexed trials
drug · Product Intelligence
Magnesium Sulfate
Pipeline Intelligence
Magnesium Sulfate: 3 indexed trials, 3 sponsors; 4 linked Orange Book patents and 13 FDA-linked events where matched.
3Sponsors
4Orange Book patent links
13FDA-linked events
Development evidence
NCT02454322Northwestern University · depressionCOMPLETED
NCT03494517Pascal Vuilleumier · epilepsyUNKNOWN
NCT05743725Assiut University · neuro_oncologyNA
FDA / patent evidence
12290529SUFLAVE · app 2153442044-08-02
12239659SUFLAVE · app 2153442044-06-14
12433914SUFLAVE · app 2153442044-06-14
12594298SUFLAVE · app 2153442044-06-14
Regulatory context
FDA_EXCLUSIVITYSUFLAVE · NP2026-06-15
FDA_EXCLUSIVITYMAGNESIUM SULFATE · CGT2026-02-01
FDA_APPROVALMAGNESIUM SULFATE · 2025-05-28
FDA_APPROVALSODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE · 2023-12-29
FDA_APPROVALSUFLAVE · 2023-06-15
FDA_APPROVALMAGNESIUM SULFATE IN PLASTIC CONTAINER · 2021-11-08
FDA_APPROVALMAGNESIUM SULFATE · 2021-04-26
FDA_APPROVALMAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER · 2020-10-27
FDA_APPROVALMAGNESIUM SULFATE IN PLASTIC CONTAINER · 2016-03-15
FDA_APPROVALMAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER · 2016-03-07
FDA_APPROVALMAGNESIUM SULFATE · 2016-01-29
FDA_APPROVALSUCLEAR · 2013-01-18
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.